Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

June 1, 1989; Volume 30,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bischof-delaloye, Angelika

    1. You have access
      Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction
      B. Leonard Holman, Robert S. Hellman, Stanley J. Goldsmith, Ismael G. Mena, Jean Leveille, Paolo Gerundini Gherardi, Jean-Luc Moretti, Angelika Bischof-Delaloye, Thomas C. Hill, Pierre M. Rigo, Ronald L. Van Heertum, Peter J. Ell, Udalrich Buell, Michel C. De Roo and Robert A. Morgan
      Journal of Nuclear Medicine June 1, 1989, 30 (6) 1018-1024;
  2. Brihaye, Claude

    1. You have access
      Clinical Usefulness of Ultrashort-Lived Iridium-191m from a Carbon-Based Generator System for the Evaluation of the Left Ventricular Function
      Philippe R. Franken, André A. Dobbeleir, Hamphrey R. Ham, Claude Brihaye, Marcel Guillaume, F. F. Knapp and Johan Vandevivere
      Journal of Nuclear Medicine June 1, 1989, 30 (6) 1025-1031;
  3. Buell, Udalrich

    1. You have access
      Biodistribution, Dosimetry, and Clinical Evaluation of Technetium-99m Ethyl Cysteinate Dimer in Normal Subjects and in Patients with Chronic Cerebral Infarction
      B. Leonard Holman, Robert S. Hellman, Stanley J. Goldsmith, Ismael G. Mena, Jean Leveille, Paolo Gerundini Gherardi, Jean-Luc Moretti, Angelika Bischof-Delaloye, Thomas C. Hill, Pierre M. Rigo, Ronald L. Van Heertum, Peter J. Ell, Udalrich Buell, Michel C. De Roo and Robert A. Morgan
      Journal of Nuclear Medicine June 1, 1989, 30 (6) 1018-1024;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 30, Issue 6
June 1, 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire